RBFA
gene geneOn this page
Also known as FLJ21172HsT169
Summary
RBFA (ribosome binding factor A, HGNC:26120) is a protein-coding gene on chromosome 18q23, encoding Putative ribosome-binding factor A, mitochondrial (Q8N0V3).
Predicted to be involved in rRNA processing. Located in mitochondrion.
Source: NCBI Gene 79863 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 79 total — 1 pathogenic
- MANE Select transcript:
NM_024805
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26120 |
| Approved symbol | RBFA |
| Name | ribosome binding factor A |
| Location | 18q23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ21172, HsT169 |
| Ensembl gene | ENSG00000101546 |
| Ensembl biotype | protein_coding |
| OMIM | 620768 |
| Entrez | 79863 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 2 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000262197, ENST00000306735, ENST00000586847, ENST00000591612, ENST00000593019
RefSeq mRNA: 2 — MANE Select: NM_024805
NM_001171967, NM_024805
CCDS: CCDS12021, CCDS54194
Canonical transcript exons
ENST00000306735 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000670868 | 80037330 | 80037506 |
| ENSE00000950389 | 80038505 | 80038617 |
| ENSE00000950390 | 80042135 | 80042219 |
| ENSE00001274338 | 80034434 | 80034653 |
| ENSE00002788608 | 80045774 | 80050651 |
| ENSE00003563209 | 80044212 | 80044285 |
| ENSE00003593639 | 80036668 | 80036710 |
Expression profiles
Bgee: expression breadth ubiquitous, 240 present calls, max score 92.56.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 22.3747 / max 164.6384, expressed in 1803 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 170921 | 18.6302 | 1790 |
| 170920 | 2.7062 | 1433 |
| 170919 | 1.0383 | 652 |
Top tissues by expression
268 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tendon of biceps brachii | UBERON:0008188 | 92.56 | gold quality |
| apex of heart | UBERON:0002098 | 89.42 | gold quality |
| right lobe of liver | UBERON:0001114 | 89.33 | gold quality |
| cortical plate | UBERON:0005343 | 88.55 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 88.52 | gold quality |
| right adrenal gland | UBERON:0001233 | 88.48 | gold quality |
| skin of abdomen | UBERON:0001416 | 88.42 | gold quality |
| left adrenal gland | UBERON:0001234 | 88.11 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 87.99 | gold quality |
| skin of leg | UBERON:0001511 | 87.84 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.67 | gold quality |
| adrenal cortex | UBERON:0001235 | 87.23 | gold quality |
| tibial artery | UBERON:0007610 | 86.99 | gold quality |
| popliteal artery | UBERON:0002250 | 86.98 | gold quality |
| gastrocnemius | UBERON:0001388 | 86.90 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 86.79 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 86.72 | gold quality |
| body of pancreas | UBERON:0001150 | 86.69 | gold quality |
| cerebellar cortex | UBERON:0002129 | 86.67 | gold quality |
| aorta | UBERON:0000947 | 86.62 | gold quality |
| adrenal gland | UBERON:0002369 | 86.58 | gold quality |
| muscle of leg | UBERON:0001383 | 86.53 | gold quality |
| right coronary artery | UBERON:0001625 | 86.51 | gold quality |
| ganglionic eminence | UBERON:0004023 | 86.49 | gold quality |
| left coronary artery | UBERON:0001626 | 86.46 | gold quality |
| omental fat pad | UBERON:0010414 | 86.45 | gold quality |
| peritoneum | UBERON:0002358 | 86.42 | gold quality |
| heart left ventricle | UBERON:0002084 | 86.35 | gold quality |
| ascending aorta | UBERON:0001496 | 86.34 | gold quality |
| thoracic aorta | UBERON:0001515 | 86.30 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.48 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
89 targeting RBFA, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-432-3P | 100.00 | 67.86 | 705 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-329-3P | 99.91 | 66.56 | 1234 |
| HSA-MIR-362-3P | 99.91 | 66.38 | 1267 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
Literature-anchored findings (GeneRIF, showing 2)
- (1)H, (13)C, and (15)N resonance assignments and solution structures of the KH domain of human ribosome binding factor A, mtRbfA, involved in mitochondrial ribosome biogenesis. (PMID:35666428)
- The recognition mode between hsRBFA and mitoribosome 12S rRNA during mitoribosomal biogenesis. (PMID:36620886)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rbfa | ENSDARG00000073705 |
| mus_musculus | Rbfa | ENSMUSG00000024570 |
| rattus_norvegicus | Rbfa | ENSRNOG00000055647 |
| drosophila_melanogaster | CG15916 | FBGN0030704 |
| caenorhabditis_elegans | WBGENE00007731 |
Protein
Protein identifiers
Putative ribosome-binding factor A, mitochondrial — Q8N0V3 (reviewed: Q8N0V3)
All UniProt accessions (1): Q8N0V3
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Mitochondrion.
Similarity. Belongs to the RbfA family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N0V3-1 | 1, p38 | yes |
| Q8N0V3-2 | 2, p27 |
RefSeq proteins (2): NP_001165438, NP_079081* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000238 | RbfA | Family |
| IPR015946 | KH_dom-like_a/b | Homologous_superfamily |
| IPR020053 | Ribosome-bd_factorA_CS | Conserved_site |
| IPR023799 | RbfA_dom_sf | Homologous_superfamily |
| IPR039212 | RBFA_mitochondrial | Family |
Pfam: PF02033
UniProt features (23 total): helix 6, strand 4, sequence variant 3, region of interest 2, compositionally biased region 2, splice variant 2, transit peptide 1, chain 1, sequence conflict 1, turn 1
Structure
Experimental structures (PDB)
20 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8IPL | X-RAY DIFFRACTION | 2.2 |
| 8CSS | ELECTRON MICROSCOPY | 2.36 |
| 8CSR | ELECTRON MICROSCOPY | 2.54 |
| 7PNX | ELECTRON MICROSCOPY | 2.76 |
| 8CST | ELECTRON MICROSCOPY | 2.85 |
| 7PO0 | ELECTRON MICROSCOPY | 2.9 |
| 9G5C | ELECTRON MICROSCOPY | 3 |
| 9G5D | ELECTRON MICROSCOPY | 3 |
| 9H54 | ELECTRON MICROSCOPY | 3 |
| 8CSU | ELECTRON MICROSCOPY | 3.03 |
| 7PNY | ELECTRON MICROSCOPY | 3.06 |
| 7PNZ | ELECTRON MICROSCOPY | 3.09 |
| 8IPM | X-RAY DIFFRACTION | 3.1 |
| 9H51 | ELECTRON MICROSCOPY | 3.1 |
| 9G5B | ELECTRON MICROSCOPY | 3.2 |
| 9H55 | ELECTRON MICROSCOPY | 3.4 |
| 9IGU | ELECTRON MICROSCOPY | 3.64 |
| 9IGT | ELECTRON MICROSCOPY | 5.96 |
| 2E7G | SOLUTION NMR | |
| 7X9U | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N0V3-F1 | 66.00 | 0.25 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 106 (showing top):
GOBP_RIBOSOME_BIOGENESIS, GOBP_RIBOSOME_ASSEMBLY, GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS, GOBP_PROTEIN_RNA_COMPLEX_ORGANIZATION, GOBP_ORGANELLE_ASSEMBLY, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOBP_RIBOSOMAL_SMALL_SUBUNIT_ASSEMBLY, PARENT_MTOR_SIGNALING_UP, GOCC_MITOCHONDRIAL_MATRIX, LEE_LIVER_CANCER_MYC_DN, GOMF_RIBOSOMAL_SMALL_SUBUNIT_BINDING, GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING, GOMF_RRNA_BINDING, GOMF_RIBOSOME_BINDING, KASLER_HDAC7_TARGETS_1_UP
GO Biological Process (3): rRNA processing (GO:0006364), mitochondrial small ribosomal subunit assembly (GO:0180026), biological_process (GO:0008150)
GO Molecular Function (3): rRNA binding (GO:0019843), ribosomal small subunit binding (GO:0043024), protein binding (GO:0005515)
GO Cellular Component (2): mitochondrion (GO:0005739), mitochondrial matrix (GO:0005759)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA processing | 1 |
| rRNA metabolic process | 1 |
| ribosome biogenesis | 1 |
| ribosomal small subunit assembly | 1 |
| mitochondrial ribosome assembly | 1 |
| RNA binding | 1 |
| ribosome binding | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| mitochondrion | 1 |
| intracellular organelle lumen | 1 |
Protein interactions and networks
STRING
702 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RBFA | ERAL1 | O75616 | 635 |
| RBFA | SLC66A2 | Q8N2U9 | 594 |
| RBFA | METTL15 | A6NJ78 | 592 |
| RBFA | ATP5IF1 | Q9UII2 | 578 |
| RBFA | TFB1M | Q8WVM0 | 575 |
| RBFA | TRMT2B | Q96GJ1 | 571 |
| RBFA | MTIF3 | Q9H2K0 | 553 |
| RBFA | NSUN4 | Q96CB9 | 543 |
| RBFA | MRM3 | Q9HC36 | 526 |
| RBFA | MTG2 | Q9H4K7 | 516 |
| RBFA | TXNL4A | P83876 | 503 |
| RBFA | MRPL54 | Q6P161 | 496 |
| RBFA | GTPBP10 | A4D1E9 | 489 |
| RBFA | MTERF4 | Q7Z6M4 | 487 |
| RBFA | ZNF24 | P17028 | 479 |
IntAct
104 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KBTBD7 | METTL15 | psi-mi:“MI:0914”(association) | 0.730 |
| SCN2B | EXOC5 | psi-mi:“MI:0914”(association) | 0.640 |
| GYPA | TCAF2 | psi-mi:“MI:0914”(association) | 0.640 |
| CMTM5 | RBFA | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBFA | CMTM5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ERLIN1 | RBFA | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBFA | FATE1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AGTRAP | RBFA | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBFA | DERL2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LEPROTL1 | RBFA | psi-mi:“MI:0915”(physical association) | 0.560 |
| HIGD1C | RBFA | psi-mi:“MI:0915”(physical association) | 0.560 |
| CAV3 | RBFA | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | RBFA | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMIM5 | RBFA | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBFA | GPX8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ANK1 | RBFA | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYPL1 | RBFA | psi-mi:“MI:0915”(physical association) | 0.560 |
| MDK | RBFA | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBFA | CACFD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHEX | RBFA | psi-mi:“MI:0915”(physical association) | 0.560 |
| PEX12 | RBFA | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBFA | FKBP7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBFA | CMTM6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYP | RBFA | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBFA | GPR152 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBFA | ABHD5 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (83): CMTM5 (Two-hybrid), RBFA (Affinity Capture-MS), RBFA (Affinity Capture-MS), KBTBD7 (Affinity Capture-MS), METTL15 (Affinity Capture-MS), RBFA (Affinity Capture-MS), RBFA (Affinity Capture-MS), ZZEF1 (Affinity Capture-MS), TRIM69 (Affinity Capture-MS), RBFA (Affinity Capture-MS), SIRT1 (Affinity Capture-MS), HECTD3 (Affinity Capture-MS), KBTBD6 (Affinity Capture-MS), ZNF638 (Affinity Capture-MS), RBFA (Affinity Capture-MS)
ESM2 similar proteins: A2A8U2, A6H773, A6QPI4, D4A6L0, E1BBQ2, O60232, P54098, Q05B67, Q08BI9, Q148E1, Q2KI76, Q2KJ58, Q2NL34, Q32Q90, Q4R4I0, Q5C9Z4, Q5RE99, Q5SNT2, Q5T6X4, Q5T848, Q5VUE5, Q5XIJ4, Q5ZLJ4, Q6DVA0, Q6P3B9, Q7T076, Q80YR4, Q86UK7, Q8C419, Q8CEG5, Q8IYL2, Q8N0V3, Q8NC56, Q8TBN0, Q8VDV3, Q8VE22, Q8VHV8, Q921N7, Q96IL0, Q96ND0
Diamond homologs: A5FL10, Q6P3B9, Q8N0V3, Q31D68
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
79 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 54 |
| Likely benign | 15 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 152854 | GRCh38/hg38 18q23(chr18:75875505-80252090)x1 | Pathogenic |
SpliceAI
1681 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 18:80034654:G:GG | donor_gain | 1.0000 |
| 18:80034650:CCAAG:C | donor_loss | 0.9900 |
| 18:80034651:CAAG:C | donor_loss | 0.9900 |
| 18:80034652:AAGTA:A | donor_loss | 0.9900 |
| 18:80034653:AGTAA:A | donor_loss | 0.9900 |
| 18:80034655:T:A | donor_loss | 0.9900 |
| 18:80036665:A:G | acceptor_gain | 0.9900 |
| 18:80036666:A:AG | acceptor_gain | 0.9900 |
| 18:80036667:G:GG | acceptor_gain | 0.9900 |
| 18:80037322:T:A | acceptor_gain | 0.9900 |
| 18:80037325:T:TA | acceptor_gain | 0.9900 |
| 18:80037326:G:A | acceptor_gain | 0.9900 |
| 18:80044207:TGTA:T | acceptor_loss | 0.9900 |
| 18:80044208:GTA:G | acceptor_loss | 0.9900 |
| 18:80044209:TA:T | acceptor_loss | 0.9900 |
| 18:80044210:A:AG | acceptor_gain | 0.9900 |
| 18:80044210:AG:A | acceptor_loss | 0.9900 |
| 18:80044211:G:GG | acceptor_gain | 0.9900 |
| 18:80044211:G:GT | acceptor_loss | 0.9900 |
| 18:80044211:GCTT:G | acceptor_gain | 0.9900 |
| 18:80046149:G:GT | donor_gain | 0.9900 |
| 18:80034653:AG:A | donor_loss | 0.9800 |
| 18:80036664:A:AG | acceptor_gain | 0.9800 |
| 18:80045768:TCCCA:T | acceptor_loss | 0.9800 |
| 18:80045769:CCCA:C | acceptor_loss | 0.9800 |
| 18:80045770:CCAG:C | acceptor_loss | 0.9800 |
| 18:80045771:CAG:C | acceptor_loss | 0.9800 |
| 18:80045772:A:AC | acceptor_loss | 0.9800 |
| 18:80034649:ACCAA:A | donor_gain | 0.9700 |
| 18:80044211:GC:G | acceptor_gain | 0.9700 |
AlphaMissense
2240 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 18:80042185:T:C | F181S | 0.990 |
| 18:80042184:T:C | F181L | 0.987 |
| 18:80042186:T:A | F181L | 0.987 |
| 18:80042186:T:G | F181L | 0.987 |
| 18:80042179:T:A | I179K | 0.983 |
| 18:80038544:T:A | W140R | 0.979 |
| 18:80038544:T:C | W140R | 0.979 |
| 18:80038546:G:C | W140C | 0.978 |
| 18:80038546:G:T | W140C | 0.978 |
| 18:80042143:T:C | L167S | 0.976 |
| 18:80042185:T:G | F181C | 0.975 |
| 18:80037448:T:C | L107P | 0.974 |
| 18:80038532:T:C | C136R | 0.974 |
| 18:80038536:G:C | R137P | 0.972 |
| 18:80042179:T:G | I179R | 0.972 |
| 18:80042135:G:C | R164S | 0.969 |
| 18:80042135:G:T | R164S | 0.969 |
| 18:80037439:T:C | L104P | 0.966 |
| 18:80038617:G:T | R164M | 0.963 |
| 18:80042173:C:A | P177Q | 0.963 |
| 18:80038534:C:G | C136W | 0.961 |
| 18:80045866:T:C | I248T | 0.961 |
| 18:80038617:G:C | R164T | 0.959 |
| 18:80038545:G:C | W140S | 0.957 |
| 18:80038593:T:C | L156P | 0.957 |
| 18:80037418:A:T | N97I | 0.955 |
| 18:80037499:T:A | L124H | 0.954 |
| 18:80042140:T:C | L166P | 0.950 |
| 18:80042173:C:G | P177R | 0.950 |
| 18:80045879:A:C | K252N | 0.950 |
dbSNP variants (sampled 300 via entrez): RS1000052986 (18:80048544 A>G), RS1000302398 (18:80041945 C>T), RS1000309384 (18:80037342 T>C), RS1000471081 (18:80040260 C>G,T), RS1000919922 (18:80036871 C>A,T), RS1001105098 (18:80042019 C>T), RS1001311303 (18:80042380 C>T), RS1001320106 (18:80035907 G>A), RS1001368912 (18:80046972 A>G), RS1001460809 (18:80046792 A>G), RS1001900867 (18:80051000 G>T), RS1002123812 (18:80047068 T>C), RS1002310232 (18:80037425 C>T), RS1002406824 (18:80047321 G>A), RS1002757325 (18:80041830 C>T)
Disease associations
OMIM: gene MIM:620768 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases methylation, decreases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, increases expression | 2 |
| Silicon Dioxide | increases expression, decreases expression | 2 |
| Valproic Acid | affects expression, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| jinfukang | increases expression | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Copper | affects binding, decreases expression | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Formaldehyde | decreases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tunicamycin | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Thapsigargin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.